DMII

Drugs Made In America Acquisition II Corp

51 hedge funds and large institutions have $343M invested in Drugs Made In America Acquisition II Corp in 2025 Q4 according to their latest regulatory filings, with 51 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
51
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change
Change in
Stake
MF
1
Magnetar Financial
Illinois
$26.7M
GCL
2
Glazer Capital LLC
New York
$23.3M
FTCM
3
First Trust Capital Management
Illinois
$20.5M
Hudson Bay Capital Management
4
Hudson Bay Capital Management
Connecticut
$19.5M
TCM
5
Tenor Capital Management
New York
$14.8M
PAMP
6
Polar Asset Management Partners
Ontario, Canada
$14.8M
Millennium Management
7
Millennium Management
New York
$14.8M
HIM
8
HGC Investment Management
Ontario, Canada
$12.2M
AA
9
AQR Arbitrage
Connecticut
$11.4M
KIM
10
Karpus Investment Management
New York
$11.3M
AC
11
Aristeia Capital
Connecticut
$10.9M
WAM
12
Wolverine Asset Management
Illinois
$10.5M
D.E. Shaw & Co
13
D.E. Shaw & Co
New York
$9.9M
DKCM
14
Davidson Kempner Capital Management
New York
$9.9M
OAC
15
OMERS Administration Corp
Ontario, Canada
$9.9M
Two Sigma Investments
16
Two Sigma Investments
New York
$8.78M
PMAM
17
Picton Mahoney Asset Management
Ontario, Canada
$8.66M
CL
18
CSS LLC
Illinois
$7.98M
HighTower Advisors
19
HighTower Advisors
Illinois
$7.82M
GCM
20
Ghisallo Capital Management
Massachusetts
$7.42M
CCM
21
Context Capital Management
California
$7.42M
MCM
22
Moore Capital Management
New York
$7.42M
RCM
23
Radcliffe Capital Management
Pennsylvania
$5.7M
WCMNY
24
Westchester Capital Management (New York)
New York
$4.95M
HI
25
HBK Investments
Texas
$4.95M